Omega Healthcare Investors Inc
Q1 2026 Earnings
Market Reaction
S&P 500 over the same 30 days: +6.60%.
Did OHI Beat Earnings? Q1 2026 Results
Omega Healthcare Investors posted a solid first quarter for fiscal 2026, extending its beat streak to four consecutive quarters as adjusted FFO of $0.82 per diluted share landed ahead of the $0.48 consensus estimate, while revenue climbed 16.7% year-over-year to $322.95 million. The headline growth was driven by higher rental income, new investment activity, and a recovery of credit losses, with GAAP net income rising to $158.58 million from $112.06 million in the year-ago period. A particularly notable catalyst was the company's $251.00 million in new Q1 investments, including a 9.9% equity stake in Saber Healthcare and its first Canadian development loan, signaling a deliberate expansion beyond traditional triple-net leases into RIDEA structures and international markets. The planned $480.00 million disposition of 18 underperforming CommuniCare facilities, twelve of which closed in April, further sharpens the portfolio's quality profile. Looking ahead, management lifted its full-year 2026 AFFO guidance midpoint by $0.02 to $3.22 per diluted share, reflecting continued confidence in operator fundamentals as trailing EBITDAR coverage improved to 1.58x.
- FAD per share up 9.5% year-over-year driven by accretive investment activity and active portfolio management
- Rental income increased to $266.9 million from $228.4 million year-over-year
- Recovery of credit losses of $3.3 million vs. provision of $5.1 million in Q1 2025
- Operator coverage metrics continued to modestly improve, with EBITDAR coverage (after management fees) reaching 1.58x for twelve months ended December 31, 2025
- Occupancy stable at 82.6% for twelve months ended December 31, 2025
- New resident fees and services income of $6.7 million from RIDEA-structured senior housing operations
“We are pleased to report strong first quarter results, with FAD per share up 9.5% over the same quarter last year. This reflects our continued accretive investment activity, augmented by active portfolio management. As a result of our strong start to 2026, we were able to increase the low end of our AFFO guidance, moving the midpoint up by two cents to $3.22.”
Omega Healthcare Investors CEO, on the earnings call
Forward Guidance & Outlook
Omega raised its full-year 2026 Adjusted FFO guidance midpoint by $0.02 to $3.22 per diluted share, with the updated range of $3.19 to $3.25 per share (previously $3.15 to $3.25). Guidance assumes all disclosed new investments, Genesis continuing full contractual rent of $13.3 million per quarter, Maplewood paying $19.5 million per quarter, quarterly G&A of $14-15 million, sale of 18 CommuniCare facilities for $480 million, conversion of $65 million in maturing mortgages to fee simple real estate, and repayment of $224 million in non-real estate backed loans throughout 2026. Guidance excludes additional acquisitions, capital markets activity, interest refinancing expenses, and provisions for credit losses.
OHI YoY Financials
OHI Revenue by Segment
Figures from SEC filings and company reports. Not investment advice.